Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2020-03-13 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOURS (37100), Indre-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU MAINE : revenue, balance sheet and financial ratios
PHARMACIE DU MAINE is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOURS (37100),
this company of category PME
shows in 2025 a net income positive of 148 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MAINE (SIREN 882453947)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
148 156 €
138 222 €
176 709 €
293 847 €
72 790 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
En 2025, PHARMACIE DU MAINE genera un resultado neto positivo de 148 k€. Evolución 2021-2025: 73 k€ -> 148 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
148 156 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 208%. Situación crítica: la deuda supera significativamente los fondos propios. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 29%. El equilibrio entre fondos propios y deuda es satisfactorio.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
208.392%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.227%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
345.468
113.964
91.964
80.472
208.392
Financial autonomy
19.471
38.078
46.527
49.697
29.227
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Ratio de endeudamiento
208.392025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+19 pts over 3 years
En 2025, el ratio de endeudamiento de PHARMACIE DU MAINE (208.39) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.
Autonomía financiera
29.23%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-22 pts over 3 years
En 2025, el autonomía financiera de PHARMACIE DU MAINE (29.2%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.
Liquidity ratios
El ratio de liquidez se sitúa en 453.17. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
453.171
Liquidity indicators evolution PHARMACIE DU MAINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
2025
Liquidity ratio
244.233
278.151
448.364
435.562
453.171
Interest coverage
None
None
None
None
None
Sector positioning
Ratio de liquidez
453.172025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excelente
En 2025, el ratio de liquidez de PHARMACIE DU MAINE (453.17) se sitúa en el top 25% del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio superior a 1 asegura cobertura cómoda de vencimientos a corto plazo.
Positioning of PHARMACIE DU MAINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU MAINE is estimated at
2 353 475 €
(range 1 597 079€ - 3 692 927€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1597k€2353k€3692k€
2 353 475 €Range: 1 597 079€ - 3 692 927€
NAF 5 année 2025
Valuation method used
Net Income Multiple
148 156 €
×
15.9x
=2 353 476 €
Range: 1 597 080€ - 3 692 927€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MAINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MAINE
What is the revenue of PHARMACIE DU MAINE ?
The revenue of PHARMACIE DU MAINE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU MAINE profitable?
Yes, PHARMACIE DU MAINE generated a net profit of 148 k€ in 2025.
Where is the headquarters of PHARMACIE DU MAINE ?
The headquarters of PHARMACIE DU MAINE is located in TOURS (37100), in the department Indre-et-Loire.
Where to find the tax return of PHARMACIE DU MAINE ?
The tax return of PHARMACIE DU MAINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MAINE operate?
PHARMACIE DU MAINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart